{
"@context": "https://schema.org",
"@type": "Article",
"headline": "FDA Sets the Stage for Cures Act Breakthrough Devices Program in Highly Anticipated Guidance Document",
"url": "https://www.lexblog.com/2017/10/25/fda-sets-the-stage-for-cures-act-breakthrough-devices-program-in-highly-anticipated-guidance-document/",
"identifier": {
"@type": "PropertyValue",
"name": "LexBlog Library record",
"value": "LEX-WK-EP7BRSX1",
"url": "https://www.lexblog.com/lib/EP7BRSX1/"
},
"datePublished": "2017-10-25T13:01:58-04:00",
"dateModified": "2019-04-30T08:33:10-04:00",
"author": {
"@type": "Person",
"name": "Kevin Madagan, Nicole Aiken-Shaban"
},
"sourceOrganization": {
"@type": "Organization",
"name": "Reed Smith LLP"
},
"organizationScope": "at-publication",
"isPartOf": "Life Sciences Legal Update",
"about": "Health Care and Life Sciences",
"sourceUrl": "https://www.lifescienceslegalupdate.com/?p=5334",
"sourceStability": "may-move"
}